Regulation of the MAP Kinase Pathway in Senescence
Regulation of the MAP Kinase Pathway in Senescence
批准号:
6941597
负责人:
GEORGE C PRENDERGAST
金额:
$35.21万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2007-08-31
关键词:
DNA replicationWI38 cellbiological signal transductionbiological transportcell fusioncell nucleuscell senescenceenzyme activityfibroblastsgel electrophoresisgel filtration chromatographyimmunoprecipitationmitogen activated protein kinasephosphomonoesterasesphosphorylationsimian virus 40virus antigenwestern blottings
中文摘要
描述(申请人提供):复制性衰老的特征是
由众多细胞过程的普遍失调所致。然而,
体外衰老细胞的特征是不能通过DNA对有丝分裂原做出反应
合成和细胞分裂。我们之前的研究表明,
增殖性反应主要基于信号失灵和这些
发生在受体结合的下游。MAP激酶途径就是该途径
大多数与有丝分裂反应有关。我们已经检查了丰富度
以及这一途径中各种中间体的活性。尽管有
有丝分裂原的某些变化刺激青年和青年之间ERK活性的增加
当按每毫克蛋白质计算时,衰老细胞的活性是
一样的。衰老过程中最戏剧性的变化是
P-ERK在衰老细胞的胞核中表达。这与失败是一致的
衰老细胞对p-ERK的磷酸化?S靶点,ELK-1。
本项目中提出的实验将解决失败的机制
核内p-ERK易位。我们将研究p-ERK的二聚化是否
需要运输的,在老化中是有缺陷的。我们将研究
年轻和衰老细胞胞核中的磷酸酶活性。我们会
确定是否加速了p-ERK从细胞核的输出
衰老细胞中是否存在核锚(S)失效。在……里面
此外,我们将确定在衰老患者中恢复p-ERK的后果。
细胞,最后我们将使用SV40T抗原作为探针的机制
核内p-ERK的大分子组装的基础。我们的目标是
了解MAP激酶丝裂原信号失活的机制
培养中的转导作为衰老过程中信号失灵的模型。
英文摘要
DESCRIPTION (provided by applicant): Replicative senescence is characterized
by a general dysregulation of numerous cellular processes. However, the
hallmark of senescent cells in vitro is failure to respond to mitogens by DNA
synthesis and cell division. Our previous studies have shown that failure of
the proliferative response is based primarily in signaling failures and these
occur downstream of receptor binding. The MAP Kinase pathway is the pathway
most associated with the mitogenic response. We have examined the abundance
and activity of various intermediates in this pathway. Although there were
some changes in mitogen stimulated increases in ERK activity between young and
senescent cells, when calculated per mg of protein, the activities were the
same. The most dramatic change in senescence was the much reduced abundance of
p-ERK in the nucleus of senescent cells. This was consistent with the failure
of senescent cells to phosphorylate p-ERK?s target, Elk-1.
The experiments proposed in this project will address the mechanism of failed
translocation of nuclear p-ERK. We will examine whether dimerization of p-ERK
required for transport, is defective in senescence. We will examine
phosphatase activity in the nucleus of young and senescent cells. We will
determine whether there is accelerated export of p-ERK from the nucleus and
whether there is failure of a nuclear anchor(s) in senescent cells. In
addition, ?we will determine the consequences of restoring p-ERK in senescent
cells and finally we will use SV40 T antigen as a probe of the mechanisms
underlying the macromolecular assembly of nuclear p-ERK. Our goal is to
understand the mechanisms underlying the failure in MAP Kinase mitogen signal
transduction in culture as a model for signaling failures in aging.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Metabolic stabilization of MAP kinase phosphatase-2 in senescence of human fibroblasts.
MAP 激酶磷酸酶-2 在人成纤维细胞衰老过程中的代谢稳定。
DOI:
10.1016/s0014-4827(03)00309-4
发表时间:
2003
期刊:
Experimental cell research
影响因子:
3.7
作者:
[Torres,Claudio, Francis,MaryKay, Lorenzini,Antonello, Tresini,Maria, Cristofalo,VincentJ]
通讯作者:
Cristofalo,VincentJ
Proteasome inhibitors shorten replicative life span and induce a senescent-like phenotype of human fibroblasts.
蛋白酶体抑制剂会缩短人类成纤维细胞的复制寿命并诱导衰老样表型。
DOI:
10.1002/jcp.20630
发表时间:
2006
期刊:
Journal of cellular physiology
影响因子:
5.6
作者:
[Torres,Claudio, Lewis,Lindsey, Cristofalo,VincentJ]
通讯作者:
Cristofalo,VincentJ
DOI:
10.1016/j.freeradbiomed.2007.10.002
发表时间:
2008-02
期刊:
Free radical biology & medicine
影响因子:
7.4
作者:
[C. Torres;V. Pérez]
通讯作者:
C. Torres;V. Pérez
Modulation of replicative senescence of diploid human cells by nuclear ERK signaling.
通过核 ERK 信号调节二倍体人类细胞的复制衰老。
DOI:
10.1074/jbc.m604955200
发表时间:
2007
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Tresini,Maria, Lorenzini,Antonello, Torres,Claudio, Cristofalo,VincentJ]
通讯作者:
Cristofalo,VincentJ
Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis
-
批准号:10346402
-
项目类别:
-
资助金额:$59.94万
-
财政年份:2022
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis
-
批准号:10548215
-
项目类别:
-
资助金额:$54.03万
-
财政年份:2022
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO2 Targeting in Pancreatic Cancer
-
批准号:8965168
-
项目类别:
-
资助金额:$40.77万
-
财政年份:2015
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
OPPC targeting to improve pancreatic cancer treatment
-
批准号:8508202
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2012
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO2 Targeting for pancreatic cancer treatment
-
批准号:8102679
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2011
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO2 Targeting for pancreatic cancer treatment
-
批准号:8338893
-
项目类别:
-
资助金额:$17.44万
-
财政年份:2011
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO inhibitors for combinatorial cancer therapy
-
批准号:8206194
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2005
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO Inhibitors for Combinatorial Cancer Therapy
-
批准号:6925262
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2005
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO inhibitors for combinatorial cancer therapy
-
批准号:8677735
-
项目类别:
-
资助金额:$23.29万
-
财政年份:2005
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO inhibitors for combinatorial cancer therapy
-
批准号:8476989
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2005
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO Inhibitors for Combinatorial Cancer Therapy
-
批准号:7224863
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2005
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO Inhibitors for Combinatorial Cancer Therapy
-
批准号:7027648
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2005
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
IDO inhibitors for combinatorial cancer therapy
-
批准号:8302267
-
项目类别:
-
资助金额:$24.42万
-
财政年份:2005
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
RhoB Signaling in Cancer Suppression and Cell Suicide
-
批准号:6748527
-
项目类别:
-
资助金额:$33.38万
-
财政年份:2003
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
RhoB Signaling in Cancer Suppression and Cell Suicide
-
批准号:6890358
-
项目类别:
-
资助金额:$33.38万
-
财政年份:2003
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
RhoB Signaling in Cancer Suppression and Cell Suicide
-
批准号:7226264
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2003
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
RhoB Signaling in Cancer Suppression and Cell Suicide
-
批准号:7126134
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2003
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
RhoB Signaling in Cancer Suppression and Cell Suicide
-
批准号:7056751
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2003
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
RhoB Signaling in Cancer Suppression and Cell Suicide
-
批准号:6598431
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2003
-
负责人:GEORGE C PRENDERGAST
-
依托单位:
ROLE OF RHO IN FARNESYLTRANSFERASE INHIBITOR RESPONSES
-
批准号:6173589
-
项目类别:
-
资助金额:$17.02万
-
财政年份:1999
-
负责人:GEORGE C PRENDERGAST
-
依托单位: